Clinical trial
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A
NCT00000116 · Carol Weigel DiFranco, NIH · Completed
Key facts
| NCT number | NCT00000116 |
|---|---|
| Title | Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A |
| Official title | Clinical Trial of Docosahexaenoic Acid (DHA) in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment |
| Lead sponsor | Carol Weigel DiFranco, NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Dietary Supplement |
| Interventions | Vitamin A, Docosahexaenoic acid, Control fatty acid |
| Enrollment | 221 |
| Start date | May 1, 1996 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Sep 24, 1999 |
| Last update posted | Mar 8, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: